Recently, Patterson et al. [29] have demonstrated a trend towards a significant increase in GM-CSF serum concentrations in non-fibrotic pulmonary sacroidosis, but not in fibrotic pulmonary sarcoidosis. This evidence concerns the gene CSF2 and pulmonary sarcoidosis.